Tähtelä R - Search Results

1

A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.

Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T. Välimäki MJ, et al. Among authors: tahtela r. Bone Marrow Transplant. 1999 Feb;23(4):355-61. doi: 10.1038/sj.bmt.1701586. Bone Marrow Transplant. 1999. PMID: 10100579 Clinical Trial.

2

The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study.

Välimäki MJ, Laitinen KA, Tähtelä RK, Hirvonen EJ, Risteli JP. Välimäki MJ, et al. Among authors: tahtela rk. Am J Obstet Gynecol. 2003 Nov;189(5):1213-20. doi: 10.1067/s0002-9378(03)00757-9. Am J Obstet Gynecol. 2003. PMID: 14634543 Clinical Trial.

3

Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin.

Sairanen S, Tähtelä R, Laitinen K, Karonen SL, Välimäki MJ. Sairanen S, et al. Among authors: tahtela r. Calcif Tissue Int. 1994 Nov;55(5):349-52. doi: 10.1007/BF00299313. Calcif Tissue Int. 1994. PMID: 7866915 Clinical Trial.

4

Mechanisms of hypocalcemia and markers of bone turnover in alcohol-intoxicated drinkers.

Laitinen K, Tähtelä R, Luomanmäki K, Välimäki MJ. Laitinen K, et al. Among authors: tahtela r. Bone Miner. 1994 Mar;24(3):171-9. doi: 10.1016/s0169-6009(08)80134-1. Bone Miner. 1994. PMID: 7912594

5

Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy.

Toivonen J, Tähtelä R, Laitinen K, Risteli J, Välimäki MJ. Toivonen J, et al. Among authors: tahtela r. Eur J Endocrinol. 1998 Jun;138(6):667-73. doi: 10.1530/eje.0.1380667. Eur J Endocrinol. 1998. PMID: 9678534

6

A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.

Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M. Välimäki MJ, et al. Among authors: tahtela r. Osteoporos Int. 1999;10(2):128-36. doi: 10.1007/s001980050207. Osteoporos Int. 1999. PMID: 10501793 Clinical Trial.

7

Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation.

Kananen K, Volin L, Tähtelä R, Laitinen K, Ruutu T, Välimäki MJ. Kananen K, et al. Among authors: tahtela r. Bone Marrow Transplant. 2002 Jan;29(1):33-9. doi: 10.1038/sj.bmt.1703317. Bone Marrow Transplant. 2002. PMID: 11840142

8

Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.

Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ. Tähtelä R, et al. Osteoporos Int. 2005 Sep;16(9):1109-16. doi: 10.1007/s00198-004-1819-7. Epub 2004 Dec 17. Osteoporos Int. 2005. PMID: 15605190 Clinical Trial.

9

The dose-dependency of alcohol-induced hypoparathyroidism, hypercalciuria, and hypermagnesuria.

Laitinen K, Tähtelä R, Välimäki M. Laitinen K, et al. Among authors: tahtela r. Bone Miner. 1992 Oct;19(1):75-83. doi: 10.1016/0169-6009(92)90845-5. Bone Miner. 1992. PMID: 1422307

10

Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links.

Välimäki MJ, Tähtelä R, Jones JD, Peterson JM, Riggs BL. Välimäki MJ, et al. Among authors: tahtela r. Eur J Endocrinol. 1994 Sep;131(3):258-62. doi: 10.1530/eje.0.1310258. Eur J Endocrinol. 1994. PMID: 7921210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters